LG Display 034220 stock outlook 2026. A careful look at the shift from LCD to large and small OLED, the Guangzhou LCD sale, the return-to-profit story, Apple dependence, debt and balance-sheet repair, past rights issues, and BOE competition risk.
A 2026 outlook on Mirae Asset Securities (KRX 006800): Korea's largest-equity brokerage, its overseas subsidiaries (US, India, Vietnam), pension and ETF platform (TIGER, Global X), IB and trading earnings volatility, buyback-and-dividend shareholder returns, real-estate PF risk, and the value-up angle for global investors.
SK IE Technology (SKIET, KRX 361610) stock outlook for 2026, covering its global wet-separator leadership, weak utilization and margins from the EV demand chasm, low-cost Chinese separator competition, Poland expansion and cell-maker customer mix, capex and balance-sheet strain, the FCW flexible cover window business, SK Innovation group governance, the turnaround question, and what US-based investors should weigh on currency and taxes.
HD Hyundai 267250 stock outlook 2026. A deep look at the Korean holding company behind shipbuilding, refining, construction equipment, and power-grid subsidiaries: NAV discount, sum-of-the-parts valuation, shipbuilding super-cycle and AI power boom exposure, dividend policy, and governance risks for US-based investors.
Coway (KRX 021240) 2026 stock outlook for global investors. A deep dive into its water purifier, air purifier, and BEREX mattress rental subscription model (account count and churn), stable cash flow and dividends, growth in Malaysia, the US, and Thailand, the Netmarble parent-company structure, FX and consumption risks, and subscription-economy valuation.
POSCO International (KRX 047050) 2026 stock outlook. A qualitative deep dive into the Myanmar gas field (E&P) cash cow, LNG terminal and trading value chain, grain and food business, EV drive-motor core growth, POSCO group governance, commodity and currency sensitivity, and dividends.
Classys (KRX 214150) 2026 stock outlook. A deep qualitative analysis of the Shurink HIFU lifting device and Volnewmer RF platform, the razor-blade model where devices seed recurring high-margin cartridge sales, global exports to Brazil and Japan, the Ilooda merger, and the aesthetic-spending cycle risk that defines this Korean medtech name.
CLS (Celestica) 2026 stock outlook. A qualitative deep dive into the electronics manufacturing services (EMS) and ODM business model, the CCS segment building hyperscale data center networking switches, servers and storage that ride AI infrastructure capex, the aerospace, defense and healthtech ATS segment, plus customer concentration, thin-margin and demand-cycle risks.
Commercial property insurance cost and coverage guide for 2026. Learn what it covers (building, inventory, equipment, fixtures, fire, theft, storm, business interruption), how premiums are priced, common exclusions, the claims process and how to fight a denial, plus practical ways to lower your cost as a U.S. small business owner.
DearU (376300) 2026 stock outlook. A deep, qualitative analysis of the Bubble fandom subscription platform's recurring revenue model, high operating margins, artist roster moat from SM and JYP, global expansion via Bubble for Japan, and the key risks of Weverse (HYBE) competition, artist dependency, and subscriber growth deceleration for global investors.
Doosan (KRX 000150) 2026 stock outlook. A deep qualitative look at the operating-holding-company structure that controls Doosan Enerbility (nuclear, SMR, gas turbines), Doosan Bobcat (compact construction equipment) and Doosan Robotics (cobots), plus the in-house electronics CCL business for AI-server PCBs, the holdco NAV discount, governance-restructuring risk, and how the stock tracks its listed subsidiaries.
E-scooter accident lawyer guide for 2026, including shared scooters like Lime and Bird. Learn how liability splits across rider injuries, pedestrian collisions, and device defects, how Lime/Bird waivers and arbitration clauses really work, why insurance coverage is so complicated, damages and settlement ranges, contingency fees, the statute of limitations, and exactly what to do after a crash in the U.S.
A complete guide to hiring a personal injury attorney after a gas explosion or fire burn injury in the U.S. Covers accident types (residential natural gas leaks, propane tank blasts, commercial explosions), liability of gas utilities, landlords, appliance manufacturers, and installers (premises and product liability), damages for burn treatment, lost income, pain and suffering, and punitive damages, settlement ranges, statute of limitations, and the evidence to preserve immediately after an accident.
Hankook Tire & Technology (KRX: 161390) 2026 stock outlook. A deep, qualitative analysis of its global top-7 tire position, premium high-inch and EV-specific tire mix, US Tennessee and Hungary plants, OE/RE revenue structure, the Hanon Systems acquisition and governance risk, and raw-material and freight headwinds from a dividend value-investor lens.
HK inno.N (KRX 195940) 2026 stock outlook. A qualitative deep dive into K-CAB (tegoprazan), Korea's homegrown P-CAB reflux drug and its competitive moat, the global licensing-out model, US clinical ambitions, the Condition hangover brand and IV-fluid base business, plus single-product dependence and drug-pricing risk for international investors.
Hugel (KRX 145020) 2026 stock outlook. A deep qualitative analysis of its botulinum toxin (Botulax/Letybo) and HA filler (The Chaeum) business, the US FDA approval and American aesthetics market entry, China and Europe expansion, the GS Group consortium acquisition, the toxin strain-origin litigation risk, and how a Korean challenger competes against the global Big 3.
Hyosung Advanced Materials (KRX 298050) 2026 stock outlook. A deep qualitative look at the world's leading tire cord cash cow, the carbon fiber expansion tied to hydrogen tanks, wind and aerospace, the aramid and spandex portfolio, plus auto-demand cyclicality, capacity payback risk and how global investors can access this Korean materials play.
Hyosung Heavy Industries (KRX 298040) 2026 stock outlook. Deep qualitative analysis of its extra-high-voltage transformer moat, exposure to the US and North American power-grid replacement supercycle, STATCOM and circuit-breaker power-equipment business, construction-segment volatility, order-recognition lag, raw-material and FX risk, plus a framework for US investors accessing Korean equities.
JYP Entertainment (KRX 035900) 2026 stock outlook for global K-pop investors. A qualitative deep dive into the multi-artist IP portfolio (Stray Kids, TWICE, ITZY, NMIXX), the localization strategy behind NiziU and U.S. groups, the album-tour-merch-platform revenue engine, and the artist-dependency, re-contract, and cyclicality risks that define this entertainment stock.
Kolmar Korea (KRX 161890) 2026 stock outlook. A qualitative analysis of Korea's No.1 cosmetics ODM/OEM, its direct leverage to the indie K-beauty export boom, US and China manufacturing bases, pharma CMO operations, and its HK inno.N (K-CAB) subsidiary engine. We also cover demand-cycle, customer-brand dependence, China, and FX risks for global investors.
Leeno Industrial (KRX: 058470) stock outlook for 2026. A qualitative deep dive into the global competitiveness of its Leeno Pin semiconductor test pins and IC test sockets, non-memory, AP and SoC test demand, its debt-free high-margin dividend-paying small-cap profile, customer concentration and front-end demand risks, and valuation considerations for international investors.
LS ELECTRIC (KRX 010120) 2026 stock outlook. A deep qualitative analysis of the ultra-high-voltage transformer and switchgear export super-cycle, surging AI data center power demand, smart grid and grid-electrification tailwinds, the automation (PLC and inverter) business, ESS and renewable power conversion, dividends, competition, and raw-material and currency risk.
Lunit (KRX 328130) 2026 stock outlook. A qualitative deep dive into Lunit INSIGHT for AI-assisted cancer detection in chest X-ray and mammography, Lunit SCOPE for pathology biomarkers and companion diagnostics, the Volpara acquisition opening the US breast health market, and global pharma partnerships. We weigh the path to profitability against valuation and FDA regulatory risk for this loss-making growth stock.
NBIS (Nebius Group) stock outlook for 2026. A qualitative deep dive into its Europe-based AI infrastructure and neocloud (GPU-as-a-Service) model, the Nvidia partnership and data center buildout, the Avride, Toloka and TripleTen subsidiaries, heavy capex and financing risk, and the competitive landscape against CoreWeave and the hyperscalers.